AMAT vs. UTHR

Last updated Jun 9, 2026

AMAT (Applied Materials, Inc.) and UTHR (United Therapeutics Corporation) are both stocks. AMAT operates in Semiconductor Equipment & Materials (Technology), while UTHR operates in Biotechnology (Healthcare). Over the past 10 years, AMAT returned 36.71%/yr vs 17.20%/yr for UTHR. At a 0.26 correlation, their price movements are largely independent.

Performance

AMAT vs. UTHR - Performance Comparison

The chart below illustrates the hypothetical performance of a $10,000 investment in Applied Materials, Inc. (AMAT) and United Therapeutics Corporation (UTHR). The values are adjusted to include any dividend payments, if applicable.

Returns By Period

In the year-to-date period, AMAT achieves a 91.99% return, which is significantly higher than UTHR's 11.79% return. Over the past 10 years, AMAT has outperformed UTHR with an annualized return of 36.71%, while UTHR has yielded a comparatively lower 17.20% annualized return.

AMAT

• 1D: 8.64%
• 1M: 13.17%
• YTD: 91.99%
• 6M: 83.99%
• 1Y: 197.34%
• 3Y*: 54.75%
• 5Y*: 30.69%
• 10Y*: 36.71%

UTHR

• 1D: -0.94%
• 1M: -3.58%
• YTD: 11.79%
• 6M: 13.59%
• 1Y: 67.18%
• 3Y*: 33.59%
• 5Y*: 25.53%
• 10Y*: 17.20%

*Multi-year figures are annualized to reflect compound growth (CAGR)

AMAT vs. UTHR - Yearly Performance Comparison

	2026 (YTD)	2025	2024	2023	2022	2021	2020	2019	2018	2017
AMAT Applied Materials, Inc.	91.99%	59.60%	1.13%	67.97%	-37.54%	83.64%	43.29%	89.86%	-34.92%	59.86%
UTHR United Therapeutics Corporation	11.79%	38.09%	60.46%	-20.93%	28.70%	42.35%	72.33%	-19.12%	-26.39%	3.15%

Correlation

The correlation between AMAT and UTHR is 0.14, which is low. Their price movements are largely independent, making them effective diversification partners.

	Correlation
Correlation (1Y) Calculated over the trailing 1-year period	0.14
Correlation (3Y) Calculated over the trailing 3-year period	0.11
Correlation (5Y) Calculated over the trailing 5-year period	0.14
Correlation (10Y) Calculated over the trailing 10-year period	0.21
Correlation (All Time) Calculated using the full available price history since Jun 18, 1999	0.26

The correlation between AMAT and UTHR shifts across timeframes, from 0.11 (3 years) to 0.26 (all time), reflecting how their relationship changes across market environments.

Fundamentals

Market Cap AMAT : $393.24B UTHR : $25.71B
EPS AMAT : $10.61 UTHR : $27.00
PE Ratio AMAT : 46.38 UTHR : 20.17
PEG Ratio AMAT : 5.90 UTHR : 0.66
PS Ratio AMAT : 13.60 UTHR : 8.19
PB Ratio AMAT : 16.45 UTHR : 4.36
Total Revenue (TTM) AMAT : $29.02B UTHR : $3.17B
Gross Profit (TTM) AMAT : $14.21B UTHR : $2.74B
EBITDA (TTM) AMAT : $9.92B UTHR : $1.75B

Return for Risk

AMAT vs. UTHR — Risk / Return Rank

Compare risk-adjusted metric ranks to identify better-performing investments over the past 12 months.

AMAT

AMAT Risk / Return Rank: 96
AMAT Sharpe Ratio Rank: 98
AMAT Sortino Ratio Rank: 94
AMAT Omega Ratio Rank: 95
AMAT Calmar Ratio Rank: 97
AMAT Martin Ratio Rank: 97

UTHR

UTHR Risk / Return Rank: 86
UTHR Sharpe Ratio Rank: 80
UTHR Sortino Ratio Rank: 87
UTHR Omega Ratio Rank: 87
UTHR Calmar Ratio Rank: 89
UTHR Martin Ratio Rank: 89

The rank (0–100) shows how this investment's returns compare to the risk taken. Higher = better. Based on the past 12 months of data, combining Sharpe, Sortino, and other metrics used by quantitative funds and institutional investors.

AMAT vs. UTHR - Risk-Adjusted Trends Comparison

This table presents a comparison of risk-adjusted performance metrics for Applied Materials, Inc. (AMAT) and United Therapeutics Corporation (UTHR). Risk-adjusted metrics are performance indicators that assess an investment's returns in relation to its risk, enabling a more accurate comparison of different investment options.

	AMAT	UTHR	Difference
Sharpe ratio: Return per unit of total volatility	4.15	1.36	+2.79
Sortino ratio: Return per unit of downside risk	3.81	2.76	+1.05
Omega ratio: Gain probability vs. loss probability	1.55	1.37	+0.17
Calmar ratio: Return relative to maximum drawdown	9.29	4.13	+5.17
Martin ratio: Return relative to average drawdown	26.48	10.54	+15.94
Data is calculated on a 1-year rolling basis and updated daily. The trend shows the change in the indicator over the past month.

AMAT vs. UTHR - Sharpe Ratio Comparison

The current AMAT Sharpe Ratio is 4.15, which is higher than the UTHR Sharpe Ratio of 1.36. The chart below compares the historical Sharpe Ratios of AMAT and UTHR, calculated using daily returns over the previous 12 months. A higher Sharpe Ratio indicates better risk-adjusted performance relative to the risk-free rate.

Sharpe Ratios by Period

	AMAT	UTHR	Difference
Sharpe Ratio (1Y) Calculated over the trailing 1-year period	4.15	1.36	+2.79
Sharpe Ratio (5Y) Calculated over the trailing 5-year period	0.70	0.73	-0.03
Sharpe Ratio (10Y) Calculated over the trailing 10-year period	0.86	0.49	+0.37
Sharpe Ratio (All Time) Calculated using the full available price history	0.43	0.38	+0.04

Drawdowns

AMAT vs. UTHR - Drawdown Comparison

The maximum AMAT drawdown since its inception was -85.22%, smaller than the maximum UTHR drawdown of -93.18%. Use the drawdown chart below to compare losses from any high point for AMAT and UTHR.

Drawdown Indicators

	AMAT	UTHR	Difference
Max Drawdown Largest peak-to-trough decline	-85.22%	-93.18%	+7.96%
Max Drawdown (1Y) Largest decline over 1 year	-21.37%	-16.35%	-5.02%
Max Drawdown (3Y) Largest decline over 3 years	-49.88%	-33.00%	-16.88%
Max Drawdown (5Y) Largest decline over 5 years	-55.14%	-33.00%	-22.14%
Max Drawdown (10Y) Largest decline over 10 years	-55.14%	-55.56%	+0.42%
Current Drawdown Current decline from peak	-1.90%	-8.73%	+6.83%
Average Drawdown Average peak-to-trough decline	-38.80%	-35.31%	-3.49%
Ulcer Index Depth and duration of drawdowns from previous peaks	7.49%	6.39%	+1.10%

Volatility

AMAT vs. UTHR - Volatility Comparison

Applied Materials, Inc. (AMAT) has a higher volatility of 19.01% compared to United Therapeutics Corporation (UTHR) at 5.15%. This indicates that AMAT's price experiences larger fluctuations and is considered to be riskier than UTHR based on this measure. The chart below showcases a comparison of their rolling one-month volatility.

Volatility by Period

	AMAT	UTHR	Difference
Volatility (1M) Calculated over the trailing 1-month period	19.01%	5.15%	+13.86%
Volatility (6M) Calculated over the trailing 6-month period	37.52%	26.01%	+11.51%
Volatility (1Y) Calculated over the trailing 1-year period	47.94%	49.84%	-1.90%
Volatility (5Y) Calculated over the trailing 5-year period, annualized	43.93%	35.13%	+8.80%
Volatility (10Y) Calculated over the trailing 10-year period, annualized	42.81%	35.07%	+7.74%

Dividends

AMAT vs. UTHR - Dividend Comparison

AMAT's dividend yield for the trailing twelve months is around 0.39%, while UTHR has not paid dividends to shareholders.

Position	TTM	2025	2024	2023	2022	2021	2020	2019	2018	2017	2016	2015
AMAT Applied Materials, Inc.	0.39%	0.69%	0.93%	0.75%	1.05%	0.60%	1.01%	1.36%	2.14%	0.78%	1.24%	2.14%
UTHR United Therapeutics Corporation	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%

Financials

AMAT vs. UTHR - Profitability Comparison

The chart below illustrates the profitability comparison between Applied Materials, Inc. and United Therapeutics Corporation over time, highlighting three key metrics: Gross Profit Margin, Operating Margin, and Net Profit Margin.

AMAT - Gross Margin

Gross margin is calculated as gross profit divided by revenue. For the three months ending on Jun 2026, Applied Materials, Inc. reported a gross profit of 3.95B and revenue of 7.91B. Therefore, the gross margin over that period was 49.9%.

UTHR - Gross Margin

Gross margin is calculated as gross profit divided by revenue. For the three months ending on Jun 2026, United Therapeutics Corporation reported a gross profit of 648.10M and revenue of 781.50M. Therefore, the gross margin over that period was 82.9%.

AMAT - Operating Margin

Operating margin is calculated as operating income divided by revenue. For the three months ending on Jun 2026, Applied Materials, Inc. reported an operating income of 2.52B and revenue of 7.91B, resulting in an operating margin of 31.9%.

UTHR - Operating Margin

Operating margin is calculated as operating income divided by revenue. For the three months ending on Jun 2026, United Therapeutics Corporation reported an operating income of 325.80M and revenue of 781.50M, resulting in an operating margin of 41.7%.

AMAT - Net Margin

Net margin is calculated as net income divided by revenue. For the three months ending on Jun 2026, Applied Materials, Inc. reported a net income of 2.81B and revenue of 7.91B, resulting in a net margin of 35.5%.

UTHR - Net Margin

Net margin is calculated as net income divided by revenue. For the three months ending on Jun 2026, United Therapeutics Corporation reported a net income of 274.90M and revenue of 781.50M, resulting in a net margin of 35.2%.

Frequently Asked Questions

Can I hold both AMAT and UTHR in my portfolio?

AMAT and UTHR have a correlation of 0.14, meaning they provide meaningful diversification benefit when combined. Depending on your allocation goals, holding both could reduce overall portfolio risk.

Which is riskier, AMAT or UTHR?

AMAT has higher volatility (19.01%) compared to UTHR (5.15%). In terms of maximum drawdown, AMAT dropped -85.22% vs UTHR's -93.18%.

Which has better risk-adjusted returns?

AMAT currently has the higher Sharpe Ratio (4.15 vs 1.36), meaning it's delivered slightly more return per unit of risk over the trailing 12 months. However, this ranking shifts over time - use the Risk/Return Score above for a more comprehensive view that combines Sharpe, Sortino, and other measures used by quantitative funds.